iBio
IBIO
$1.76
Share price
2.33%
Change (1 day)
62.96%
Change (1 year)
Categories
iBio (IBIO) - P/B ratio
P/B ratio as of April 2024 : 1.65
According to iBio's latest financial reports the company has a price-to-book ratio of 1.65.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
iBio - P/B ratio (from 2008 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.2987 | 40.52% |
| 2022-12-31 | 0.2126 | -83.91% |
| 2021-12-31 | 1.32 | -36.25% |
| 2020-12-31 | 2.07 | -107.93% |
| 2019-12-31 | -26.1 | -2139.66% |
| 2018-12-31 | 1.28 | -51% |
| 2017-12-31 | 2.61 | 27.37% |
| 2016-12-31 | 2.05 | -62.65% |
| 2015-12-31 | 5.50 | 6.65% |
| 2014-12-31 | 5.15 | 89.89% |
| 2013-12-31 | 2.71 | -65.94% |
| 2012-12-31 | 7.97 | -90.94% |
| 2011-12-31 | 88.0 | 87.56% |
| 2010-12-31 | 46.9 | 859.77% |
| 2009-12-31 | 4.89 | 927.82% |
| 2008-12-31 | 0.4755 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.12 | 210.73% | 🇺🇸 USA |
 Genocea Biosciences
GNCA | 0.0005 | -99.97% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | 1.85 | 12.28% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | 0.1549 | -90.60% | 🇺🇸 USA |